• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

闭塞性细支气管炎小鼠气道模型中的免疫细胞。

Immune cells in a mouse airway model of obliterative bronchiolitis.

作者信息

Neuringer I P, Mannon R B, Coffman T M, Parsons M, Burns K, Yankaskas J R, Aris R M

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, and Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Am J Respir Cell Mol Biol. 1998 Sep;19(3):379-86. doi: 10.1165/ajrcmb.19.3.3023m.

DOI:10.1165/ajrcmb.19.3.3023m
PMID:9730865
Abstract

Obliterative bronchiolitis (OB), a form of chronic lung rejection, affects 50% of all lung-transplant recipients and is a major cause of morbidity and mortality. We used the mouse tracheal allograft model of OB to quantitate inflammatory cells during disease progression to evaluate the pathogenesis of this disorder. Tracheas of BALB/c mice were implanted into C57BL/6, severe combined immunodeficiency (SCID), and BALB/c mice. Cyclosporin was administered at 25 mg/kg/d. Grafts were harvested at 2, 6, 10, and 15 wk, and analyzed immunohistochemically. Tracheal allografts developed epithelial injury and cellular infiltrates at 2 wk, epithelial denudation and complete luminal obliteration at 6 wk, and dense collagenous scarring by 15 wk. SCID allografts and isografts demonstrated intact epithelium throughout, although a mononuclear infiltrate was initially present at 2 wk in the SCID allografts. Immunohistochemical staining, using antibodies to mouse CD4(+) (T-helper lymphocyte), CD8(+) (T-cytotoxic/suppressor lymphocyte), and B lymphocytes, macrophages, and myofibroblasts, revealed large numbers of macrophages and CD4(+) and CD8(+) lymphocytes in allografts at 2 wk, compared with isografts. The allograft CD4(+)/CD8(+) ratio was 0.75 at 2 wk. Allografts demonstrated macrophage, myofibroblast, and CD4(+) predominance at 6 and 10 wk (CD4(+)/CD8(+) = 2/1), but by 15 wk had minimal cellularity and were densely scarred. SCID allografts demonstrated a macrophage-predominant infiltrate at 2 wk, with minimal cellularity at later time points. These results indicate that: (1) OB is predominantly an immunologic airway injury; and (2) CD4(+) and CD8(+) lymphocytes and macrophages play an important role in the evolution of airway inflammation and fibrosis. Additionally, this model suggests that chronic airway fibrosis follows a period of intense airway-directed, cell-mediated rejection.

摘要

闭塞性细支气管炎(OB)是一种慢性肺排斥反应,影响着50%的肺移植受者,是发病和死亡的主要原因。我们使用OB的小鼠气管同种异体移植模型来定量疾病进展过程中的炎症细胞,以评估这种疾病的发病机制。将BALB/c小鼠的气管植入C57BL/6、严重联合免疫缺陷(SCID)和BALB/c小鼠体内。以25mg/kg/d的剂量给予环孢素。在第2、6、10和15周收获移植物,并进行免疫组织化学分析。气管同种异体移植物在第2周出现上皮损伤和细胞浸润,在第6周出现上皮剥脱和管腔完全闭塞,到第15周出现致密的胶原瘢痕形成。SCID同种异体移植物和同基因移植物的上皮始终保持完整,尽管SCID同种异体移植物在第2周最初存在单核细胞浸润。使用针对小鼠CD4(+)(辅助性T淋巴细胞)、CD8(+)(细胞毒性/抑制性T淋巴细胞)以及B淋巴细胞、巨噬细胞和成肌纤维细胞的抗体进行免疫组织化学染色,结果显示与同基因移植物相比,同种异体移植物在第2周有大量巨噬细胞以及CD4(+)和CD8(+)淋巴细胞。同种异体移植物在第2周时CD4(+)/CD8(+)比值为0.75。同种异体移植物在第6和10周表现为巨噬细胞、成肌纤维细胞和CD4(+)占优势(CD4(+)/CD8(+) = 2/1),但到第15周细胞数量极少且有致密瘢痕形成。SCID同种异体移植物在第2周表现为以巨噬细胞为主的浸润,在后期时间点细胞数量极少。这些结果表明:(1)OB主要是一种免疫性气道损伤;(2)CD4(+)和CD8(+)淋巴细胞以及巨噬细胞在气道炎症和纤维化的发展中起重要作用。此外,该模型表明慢性气道纤维化发生在一段强烈的气道定向细胞介导的排斥反应之后。

相似文献

1
Immune cells in a mouse airway model of obliterative bronchiolitis.闭塞性细支气管炎小鼠气道模型中的免疫细胞。
Am J Respir Cell Mol Biol. 1998 Sep;19(3):379-86. doi: 10.1165/ajrcmb.19.3.3023m.
2
Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.气道上皮损伤在小鼠原位气管同种异体移植排斥反应中的作用。
Ann Thorac Surg. 2006 Oct;82(4):1226-33. doi: 10.1016/j.athoracsur.2006.03.122.
3
Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.肺内淋巴样新生导致的气管同种异体移植物排斥,而无次级淋巴器官参与。
Transplantation. 2012 Jun 27;93(12):1212-20. doi: 10.1097/TP.0b013e318250fbf5.
4
Hierarchical contributions of allorecognition pathways in chronic lung rejection.同种异体识别途径在慢性肺移植排斥反应中的分层作用。
Am J Respir Crit Care Med. 2003 Apr 1;167(7):999-1007. doi: 10.1164/rccm.200209-1099OC. Epub 2002 Nov 21.
5
Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.感染重组大鼠巨细胞病毒的大鼠气管同种异体移植中闭塞性气道疾病的加重
J Heart Lung Transplant. 1998 May;17(5):439-51.
6
Donor antigen-presenting cells are important in the development of obliterative airway disease.供体抗原呈递细胞在闭塞性气道疾病的发展过程中起着重要作用。
J Thorac Cardiovasc Surg. 2000 Dec;120(6):1070-7. doi: 10.1067/mtc.2000.110674.
7
Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.用于研究闭塞性细支气管炎的原位和异位气管移植模型。
Transpl Immunol. 2013 Jun;28(4):170-5. doi: 10.1016/j.trim.2013.04.006. Epub 2013 Apr 22.
8
[Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].[大鼠同种异体气管移植模型中闭塞性细支气管炎的建立及发病机制的初步检测]
Zhonghua Wai Ke Za Zhi. 2007 Feb 15;45(4):262-6.
9
Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.单独使用抗CD40配体或与供体骨髓联合使用共刺激分子阻断法,抑制异位小鼠气管移植后闭塞性气道疾病的发展。
J Heart Lung Transplant. 2005 Jul;24(7 Suppl):S232-8. doi: 10.1016/j.healun.2004.06.008.
10
T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.异位移植小鼠气管闭塞性气道疾病的T细胞和主要组织相容性复合体要求
Transplantation. 1998 Sep 27;66(6):764-71. doi: 10.1097/00007890-199809270-00011.

引用本文的文献

1
Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome.评估 EZH2 抑制在毛细支气管炎闭塞综合征小鼠模型中的治疗潜力。
Transpl Int. 2024 Oct 25;37:13227. doi: 10.3389/ti.2024.13227. eCollection 2024.
2
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway.间充质干细胞通过抑制 TGF-β-SMAD2/3 通路可逆性地将肌成纤维细胞去分化为成纤维样细胞。
Mol Med. 2023 Apr 25;29(1):59. doi: 10.1186/s10020-023-00630-9.
3
SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
T细胞中SOCS3的过表达可改善小鼠异位气管移植模型中的慢性气道阻塞。
Surg Today. 2019 May;49(5):443-450. doi: 10.1007/s00595-018-1753-5. Epub 2019 Jan 7.
4
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.肺移植研究模型:美国国立心肺血液研究所研讨会的共识声明
JCI Insight. 2017 May 4;2(9). doi: 10.1172/jci.insight.93121.
5
Engineered Tissue-Stent Biocomposites as Tracheal Replacements.工程化组织-支架生物复合材料作为气管替代物
Tissue Eng Part A. 2016 Sep;22(17-18):1086-97. doi: 10.1089/ten.TEA.2016.0132.
6
Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.异基因造血干细胞移植后闭塞性细支气管炎综合征——慢性移植物抗宿主病的一种日益被认识的表现形式。
Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S106-14. doi: 10.1016/j.bbmt.2009.11.002. Epub 2009 Nov 5.
7
CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.CD4 + T淋巴细胞对于血管化小鼠肺移植的急性排斥反应并非必需。
J Immunol. 2008 Apr 1;180(7):4754-62. doi: 10.4049/jimmunol.180.7.4754.
8
Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.吸入脂多糖通过局部先天免疫激活诱导的同种免疫性肺损伤。
Transplantation. 2007 Oct 27;84(8):1012-9. doi: 10.1097/01.tp.0000286040.85007.89.
9
Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.供体摄入酒精会加剧异位移植后的实验性气道疾病。
Am J Respir Crit Care Med. 2007 Dec 1;176(11):1161-8. doi: 10.1164/rccm.200702-255OC. Epub 2007 Aug 23.
10
Human and murine obliterative bronchiolitis in transplant.移植中的人类和小鼠闭塞性细支气管炎
Proc Am Thorac Soc. 2007 Jan;4(1):37-43. doi: 10.1513/pats.200605-107JG.